AVANIR PHARMACEUTICALS

Avanir Q1 net loss increases

Avanir Pharmaceuticals Announces Publication Of Phase III Study Results Showing Efficacy And Safety Of AVP-923 In The Treatment Of Diabetic Neuropathic Pain

Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Good Nuedexta Trends Continues, Phase 2 Progress

Avanir (AVNR) Reports Publication of Superior Results from AVP-923 Phase III Dosage Study

Avanir Pharmaceuticals' AVP-923 for diabetis shows positive Phase III results

Avanir Pharmaceuticals Announces Publication of Phase III Study Results Showing Efficacy and Safety of AVP-923 in the Treatment of Diabetic Neuropathic Pain

AVANIR Pharmaceuticals' CEO Discusses F1Q12 Results - Earnings Call Transcript

Avanir Pharmaceuticals, Inc. (AVNR) Posts Better-Than-Expected Q1 Results

Avanir Pharmaceuticals reports Q1 EPS (12c) vs. consensus (13c)

Avanir Pharmaceuticals Reports Fiscal 2012 First Quarter Financial and Business Results

Avanir Pharmaceuticals Announces Date of Fiscal 2012 First Quarter Financial Results and Conference Call

McNicoll Lewis & Vlak Starts Avanir Pharmaceuticals (AVNR) at Buy

Biotech Stock Mailbag: Celldex, Hep C Bubble, Al Mann Anger

Avanir Pharmaceuticals management to meet with JMP Securities

A No-Good, Really Bad, Awful Year for This Pharmaceutical Company

1 Massive Biotech Bloodbath

This Analyst Sees Nearly 500% Upside in Avanir Pharmaceuticals (AVNR)

3 Biotechs Making Big Moves on Big News

Avanir Pharmaceuticals Reports Operating Results (10-K)

Jefferies Cuts Price Targets on Avanir Pharmaceuticals (AVNR) as Growth Lags

Avanir, Best Buy, DuPont, MarkWest, Urban Outfitters: U.S. Equity Movers

Top Analyst Upgrades & Downgrades (MT, AVNR, CTRN, ETH,INTC, IGT, KALU, LVS, MA, MGM, MNTA, NOR, SFD, SO, SE, URBN, V, WYNN)

Avanir Pharmaceuticals Reports Fiscal 2011 Fourth Quarter and Year End Financial Results

Avanir Pharmaceuticals reports Q4 EPS (14c) vs. consensus (14c)

Avanir Pharmaceuticals Reports Fiscal 2011 Fourth Quarter and Year End Financial Results

Companies reporting After the Market Close on Monday, December 12

Avanir Pharma mentioned positively ahead of tonight's report at Summer Street

Generex Biotech and Avanir Pharmaceuticals Look to Rally in 2012

Generex Biotech and Avanir Pharmaceuticals Look to Rally in 2012

Trading Radar for 12/12: Fuelcell Energy (FCEL), Avanir Pharma (AVNR), Peregrine Pharma (PPHM), Miller Energy (MILL) Report

7 Reasons to Worry About Next Week

Avanir Pharmaceuticals (AVNR) President and CEO Keith Katkin sells 17,495 Shares

Avanir Pharmaceuticals Announces Date of Fiscal 2011 Fourth Quarter and Year End Financial Results and Conference Call

Avanir Pharmaceuticals jumps in the pre-market, resistance is at $2.56

Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Nuedexta Survey: Positive Dx and Prescribing Trends Suggest Continued Growth

Whoa! What Just Happened to My Stock?

Stocks To Watch During The Week Of Nov. 28

5 Biotechs Posting Big Gains

AVANIR (AVNR) Shares Bounce Off $2 Level, Up 26% Today

Weekly CEO Sells Highlight: KIT digital Inc, Avanir Pharmaceuticals Inc, J & J Snack Foods ...